We are the Liverpool Clinical Trials Centre

We bring together a wealth of expertise built on the experience of the Liverpool Trials Collaborative which has held full registration status with the UK Clinical Research Collaboration CTU network since its establishment in 2007.

Read more about us

Clinical Trials

Click on a Trial Name for more information.


CiPHER Phase II multicentre study assessing the efficacy of Cabazitaxel in Patients with HER2-negative metastatic breast cancer and having unresectable brain metastases
MAP-BRA A Mesh SAfety Platform for Immediate Implant based BReAst Reconstruction (MAP-BRA) Project: A multicentre prospective cohort study to evaluate the safety and effectiveness of Fortiva porcine acellular dermal matrix in immediate implant based breast reconstruction
TIP Thrombin Inhibition Preoperatively in Early Breast Cancer


ENERGIZE Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes
RESILIENT RandomisEd, controlled, double blind Study to assess mechanistic effects of combination therapy of dapagliflozin with Exenatide QW versus dapagliflozin alone in obese (BMI>30 kg/m2) patients with Type 2 diabetes mellitus.
ROMANCE A randomised, controlled multi-centre trial of 26 weeks of subcutaneous Liraglutide (a GLP-1 receptor agonist), with or without continuous positive airway pressure (CPAP) in patients with type 2 Diabetes Mellitus (T2DM) and Obstructive Sleep Apnoes (OSA)


CLL210 Phase II trial of ofatumumab, dexamethasone and lenalidomide for high-risk CLL (NCRI CLL210)
DESTINY A trial of de-escalation and stopping treatment in chronic myeloid leukaemia patients with excellent responses to tyrosine kinase inhibitor therapy (De-Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in chronic myeloid leukaemia)
PACIFICO Purine-Alkylator Combination In Follicular lymphoma Immuno-Chemotherapy for Older patients
PETReA PET-guided Response-Adapted therapy in follicular lymphoma (PETReA)
RIAltO A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL
UK CLL Trials Biobank UK CLL Trials Biobank

Head and Neck

DAHANCA-21 Hyperbaric oxygen treatment of mandibular osteoradionecrosis.
HOPON HOPON: Hyperbaric Oxygen for the Prevention of Osteoradionecrosis.
NICO CA209-891: Neoadjuvant and adjuvant nivolumab as Immune Checkpoint inhibition in Oral cavity cancer
REALISTIC A Phase I, Dose Escalation Trial Of Recombinant Listeria Monocytogenes (Lm)-Based Vaccine Encoding Human Papilloma Virus Serotype 16 Target Antigens (ADXS11-001) In Patients With HPV-16 +ve Oropharyngeal Carcinoma
SAVER Sodium Valproate for Epigenetic Re-programming in Management of High Risk Oral Epithelial Dysplasia: a randomised, double blind, placebo controlled clinical trial with embedded mechanistic and feasibility studies.
TITAN Trial of Induction TPF Therapy in Advanced Head & Neck Cancer.


ACIT-1 A Phase I clinical study to determine the optimal dose for the safe immune restoration and immune response of allogeneic cell immunotherapy (ACIT-1) in adult cancer patients
BBC-01 BBC01- BBC: Phase II study of neoadjuvant cisplatin and gemcitabine chemotherapy versus upfront surgery in patients with locally advanced / borderline resectable proximal biliary tract cancer:

Infection and Global Health

UK Meningitis TRIM: Development of a novel host blood test using TRanscripts to Identify bacterial Meningitis (uitilises clinical cohort being recruited through UK Meningitis Study)


UKLS UK Lung Cancer Screening Trial


ITEM ITEM: A Phase II Study of Imatinib in the Treatment of Patients with Metastatic Uveal Melanoma
NITRO Neo-adjuvant IntraviTreal Ranibizumab treatment in high risk Ocular melanoma patients: A two stage single centre Phase II single arm study.
SelPac A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.
SUAVE A randomised phase II study of Sunitinib versus Dacarbazine in the treatment of patients with metastatic uveal melanoma ** Recruitment is on-hold as of 08 November 2012


APRiCOT A Pilot Randomised Study to Compare Combination Antibiotic Therapy (Ciprofloxacin, Doxycycline and Hydroxychloroquine) with Standard Therapy (Budesonide) in the Treatment of Active Crohn's Disease
BEA Multifrequency Bioimpedance in the Early Detection of Lymphoedema after Axillary Surgery
BIOBehcets Optimal utilisation of biologic drugs in Behçet's Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment.
CHAMPion Cancer-induced Hypercoagulability as a marker of prognosis
CIMI DENT A pilot randomised controlled trial of coventional implants vs mini implants used to retain full lower dentures
COMICE A randomised double blinded placebo controlled Phase II clinical trial of Cediranib and Olaparib Maintenance in advanced recurrent Cervical Cancer.
HIP Hartman's procedure versus Intersphincteric abdominal excision: a Prospective observational study
PIVOTAL PIVOTAL: Pharmacological Individualisation of VOriconazole Therapy for AntifungaL treatment
PLACE Prevention of Lymphoedema after Clearance by External Compression (PLACE)
PPAC2 PPAC2: The impact of postoperative Packing of Perianal Abscess Cavities: a multicentre randomised controlled trial.
RECAP A Three arm Randomized Controlled Trial of Progesterone, Arabin Pessary and Cervical Cerclage to prevent Spontaneous Preterm Birth in an Asymptomatic High Risk Cohort with Short Cervix (RECAP)
STRIDER A Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early Onset intrauterine Growth Restriction.
UK-COMPASS A Prospective Cohort Comparison Study of Open and Endovascular Techniques for Juxtarenal and Suprarenal Abdominal Aortic Aneurysms (The UK Complex AAA Study).
UK-EDI UK Early Detection Initiative for Pancreatic Cancer

Palliative Care

BIVA Hydration in palliative cancer patients: the testing of a new assessment method
ChemdEL Chemical compatibility of drug combinations used in end of life care.
CODV A Living Community Presence – Evaluation of an innovative approach for volunteers to support the care of patients and their families in the last hours and days of life.
Demoralisation A prospective longitudinal study to determine the prevalence, aetiology and natural history of depression and demoralisation in patients with advanced metastatic cancer
INPIC Invasive Procedures In Cancer Pain
LCPC Care of the Dying Child: development, implementation and evaluation of the Liverpool Care Pathway for the Dying Child


ACELARATE A Phase III, open label, multicentre randomized clinical trial comparing Acelarin (NUC-1031) with Gemcitabine in patient with metastatic pancreatic carcinoma
ESPAC-1 European Study Group for Pancreatic Cancer Trial 1 - Adjuvant Therapy in Operable Pancreatic Cancer
ESPAC-3 / ESPAC-3(v2) European Study Group for Pancreatic Cancer (ESPAC) - Trial 3. Adjuvant Chemotherapies in Resectable Pancreatic Cancer
ESPAC-4 EUROPEAN STUDY GROUP FOR PANCREATIC CANCER (ESPAC) - Trial 4. Combination versus single agent chemotherapy in resectable pancreatic ductal and peri-ampullary cancers.
ESPAC-5F EUROPEAN STUDY GROUP FOR PANCREATIC CANCER - TRIAL 5F Four arm, prospective, multicentre, randomised feasibility trial of immediate surgery compared with neoadjuvant chemotherapies and neoadjuvant chemoradiotherapy.
EUROPAC2 European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC)2 trial to investigate the efficacy of antioxidants and magnesium for the treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis.
GEMCAP A phase III multicentre randomised clinical trial comparing gemcitabine alone or in combination with capecitabine for the treatment of patients with advanced pancreatic cancer.
PANASTA Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pacreato-duodenectomy – a double blinded multi-centred trial (Phase III).
PETPANC The Impact of combined modality positron emission tomography with computerised tomography scanning (PET/CT) in the diagnosis and management of pancreatic cancer.
TeloVac A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination gemcitabine and capecitabine therapy with concurrent and sequential chemoimmunotherapy using a telomerase vaccine in locally advanced and metastatic pancrea
VIP A prospective, phase II, double blinded, multicentre, randomised clinical trial comparing combination gemcitabine and Vandetanib therapy with gemcitabine therapy alone in locally advanced or metastatic pancreatic carcinoma


ESPAC-Tplus A Translational Study, Characterisation of Tumour Molecular Response Predictors of Chemotherapy and Radiotherapy Treatments for Pancreatic Cancer in Patients in the ESPAC Trials


NEOBLADE Phase II randomised placebo controlled Neoadjuvant chemotherapy study of Nintedanib with Gemcitabine and Cisplatin in locally advanced muscle invasive bladder cancer

All recruitment and site information is updated hourly from LCTU systems



Lost Username / Password?